5-Bromo-2-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline

Catalog No. :
ACHUZR154
CAS No. :
104737-00-0
Molecular Formula :
C10H11BrN2O2
Molecular Weight :
271.11

IUPAC Name:5-bromo-2-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline

5-Bromo-2-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$91.00Login to see priceIn stockInquiry
5g97%$301.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline
IUPAC Name5-bromo-2-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline
MDL No.MFCD09955235
Molecular FormulaC10H11BrN2O2
Molecular Weight271.11
SMILESO=[N+](C1=CC=C(Br)C2=C1CN(C)CC2)[O-]
InChI KeyDXRCGGKIRYSZQP-UHFFFAOYSA-N
Synonym104737-00-0 | 5-BROMO-2-METHYL-8-NITRO-1,2,3,4-TETRAHYDROISOQUINOLINE | 5-bromo-2-methyl-8-nitro-3,4-dihydro-1H-isoquinoline | Isoquinoline,5-bromo-1,2,3,4-tetrahydro-2-methyl-8-nitro- | DXRCGGKIRYSZQP-UHFFFAOYSA-N | SCHEMBL3020938 | DTXSID70434257 | MFCD09955235 | AKOS0
CAS No.104737-00-0
PubChem CID10016010

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACHUZR154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHUZR154 route product structure diagram
    ACHUZR154104737-00-0 In Stock
Inquiry

2. ACHUZR154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHUZR154 route product structure diagram
    ACHUZR154104737-00-0 In Stock
Inquiry

Comments (0)